Aspesi Anna, La Vecchia Marta, Sala Gloria, Ghelardi Emilia, Dianzani Irma
Department of Health Sciences, Università Del Piemonte Orientale, 28100 Novara, Italy.
Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, 56123 Pisa, Italy.
Int J Mol Sci. 2024 Dec 11;25(24):13308. doi: 10.3390/ijms252413308.
An increasingly important role for gut microbiota in the initiation and progression of colorectal cancer (CRC) has been described. Even in the early stages of transformation, i.e., colorectal adenomas, changes in gut microbiota composition have been observed, and several bacterial species, such as pks and enterotoxigenic , have been proposed to drive colon tumorigenesis. In recent years, several strategies have been developed to study mucosa-associated microbiota (MAM), which is more closely associated with CRC development than lumen-associated microbiota (LAM) derived from fecal samples. This review summarizes the state of the art about the oncogenic actions of gut bacteria and compares the different sampling strategies to collect intestinal microbiota (feces, biopsies, swabs, brushes, and washing aspirates). In particular, this article recapitulates the current knowledge on MAM in colorectal adenomas and serrated polyps, since studying the intestinal microbiota associated with early-stage tumors can elucidate the molecular mechanisms underpinning CRC carcinogenesis.
肠道微生物群在结直肠癌(CRC)的发生和发展中发挥着越来越重要的作用。即使在转化的早期阶段,即结直肠腺瘤阶段,也已观察到肠道微生物群组成的变化,并且已提出几种细菌物种,如产聚酮合酶(pks)和产肠毒素的细菌,可驱动结肠肿瘤发生。近年来,已开发出几种策略来研究与黏膜相关的微生物群(MAM),它比源自粪便样本的与管腔相关的微生物群(LAM)与CRC发展的关系更为密切。本综述总结了肠道细菌致癌作用的最新进展,并比较了收集肠道微生物群的不同采样策略(粪便、活检、拭子、刷子和冲洗吸出物)。特别是,本文概述了目前关于结直肠腺瘤和锯齿状息肉中MAM的知识,因为研究与早期肿瘤相关的肠道微生物群可以阐明CRC致癌作用的分子机制。